Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Optimization of Caffeine in Neonates With Hypoxic-Ischemic Encephalopathy

NCT06448780 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT06448780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06448780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Optimization of Caffeine in Neonates With Hypoxic-Ischemic Encephalopathy
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 26, 2024
Completion date
July 31, 2028
Enrollment
16 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic-ischemic encephalopathy